Why Iovance Biotherapeutics, Inc. (IOVA) stock fell 35.5% on Thursday, October 29, 2026

Iovance Biotherapeutics, Inc. (IOVA) traded at $9.56 as of 11:31 AM ET, down 35.46% on Thursday, October 29, 2026, on volume of 35,878,223 shares (2.2× its 3-month average); market value about $4.30B.

What happened

Nexqual found no SEC filing, earnings release, analyst rating change or insider trade for IOVA on Thursday, October 29, 2026 or October 28, 2026. The move may reflect news, sector or market moves, or trading flows that these sources do not capture.

More on IOVA

IOVA stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: October 29, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built October 29, 2026 at 16:08 UTC. Not investment advice.

Data source: Nexqual. Last updated: October 29, 2026 at 16:08 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt